Development Driven Hub & Spoke Biotech
Launching clinical stage companies to develop impactful medicines faster
Who We Are
Banyan builds and develops NewCos around high-quality therapeutic assets. We combine disciplined execution, deep development expertise, and a centralized operating model to accelerate medicines from early clinical stages to meaningful milestones.
Global Sourcing Advantage
Deep industry relationships leveraging Locust Walk's banking business and market insight enable us to identify high-potential assets with strong clinical promise.
Development-First Platform
A centralized, comprehensive clinical development organization drives faster timelines and higher probability of success.
Integrated Team
Experienced leaders across clinical, regulatory, CMC, and operations, building a growing pipeline of new medicines.
How We Work
Our approach takes programs through value creation using disciplined, end-to-end execution.
1
Source & Evaluate
Identify high-potential medicines with strong data and clear differentiation.
2
Build NewCo
Form focused companies with the right leadership, strategy, and development plans.
3
Execute & Scale
Advance programs with turnkey support across clinical development, regulatory, CMC, and operations.
Who We Partner With
We collaborate with biotech and pharma companies to rapidly advance impactful medicines.
Banyan is the Partner of Choice
Banyan is built to be a true development partner for teams seeking more than capital — offering hands-on leadership, turnkey infrastructure, and a shared commitment to advancing impactful medicines
Exceptional Team & Capabilities
Rapid deployment of experienced development leaders and a centralized platform to de-risk execution.
Turnkey NewCo Building
End-to-end support across clinical development, regulatory, CMC, quality, and operations.
Collaborative Partnerships
We work side by side with originators to align strategy, share success, and build focused companies together.
Execution That Drives Impact
A disciplined approach designed to accelerate timelines and move programs efficiently toward meaningful milestones.
Our Leadership Team
Geoff Meyerson
CEO & Chairman of Board
g.meyerson@banyan-bio.com
Barbara White
Co-founder, President, & Board Member
b.white@banyan-bio.com
Let's Get Started
Have an innovative, potentially best-in-class or first-in-class medicine with human data? Banyan partners with teams ready to build a focused NewCo and accelerate development toward meaningful clinical milestones.
Let's explore how we can work together to bring impactful medicines to patients.